Literature DB >> 22933526

Clinical and functional correlates of early microvascular dysfunction after heart transplantation.

François Haddad1, Prateeti Khazanie, Tobias Deuse, Dana Weisshaar, Jessica Zhou, Chang Wook Nam, Thu A Vu, Fatemeh A Gomari, Mehdi Skhiri, Ana Simos, Ingela Schnittger, Bojan Vrotvec, Sharon A Hunt, William F Fearon.   

Abstract

BACKGROUND: Microvascular dysfunction is emerging as a strong predictor of outcome in heart transplant recipients. At this time, the determinants and consequences of early microvascular dysfunction are not well established. The objective of the study was to determine the risk factors and functional correlates associated with early microvascular dysfunction in heart transplant recipients. METHODS AND
RESULTS: Sixty-three heart transplant recipients who had coronary physiology assessment, right heart catheterization, and echocardiography performed at the time of their first annual evaluation were included in the study. Microvascular dysfunction was assessed using the recently described index of microcirculatory resistance. The presence of microvascular dysfunction, predefined by an index of microcirculatory resistance >20, was observed in 46% of patients at 1 year. A history of acute rejection and undersized donor hearts were associated with microvascular dysfunction at 1 year, with odds ratio of 4.0 (1.3-12.8) and 3.6 (1.2-11.1), respectively. Patients with microvascular dysfunction had lower cardiac index (3.1±0.7 versus 3.5±0.7 L/min per m(2); P=0.02) and mild graft dysfunction measured by echocardiography-derived left and right myocardial performance indices ([0.54±0.09 versus 0.43±0.09; P<0.01] and [0.47±0.14 versus 0.32±0.05; P<0.01], respectively). Microvascular dysfunction was also associated with a higher likelihood of death, graft failure, or allograft vasculopathy at 5 years after transplant (hazard ratio, 2.52 [95% CI, 1.04-5.91]).
CONCLUSIONS: A history of acute rejection during the first year and smaller donor hearts were identified as risk factors for early microvascular dysfunction. Microvascular dysfunction assessed using index of microcirculatory resistances at 1 year was also associated with worse graft function and possibly worse clinical outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22933526     DOI: 10.1161/CIRCHEARTFAILURE.111.962787

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  10 in total

1.  New developments for the detection and treatment of cardiac vasculopathy.

Authors:  Kevin J Clerkin; Ziad A Ali; Donna M Mancini
Journal:  Curr Opin Cardiol       Date:  2017-02-15       Impact factor: 2.161

2.  Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation.

Authors:  William F Fearon; Kozo Okada; Jon A Kobashigawa; Yuhei Kobayashi; Helen Luikart; Sean Sana; Tiffany Daun; Steven A Chmura; Seema Sinha; Garett Cohen; Yasuhiro Honda; Michael Pham; David B Lewis; Daniel Bernstein; Alan C Yeung; Hannah A Valantine; Kiran Khush
Journal:  J Am Coll Cardiol       Date:  2017-06-13       Impact factor: 24.094

3.  Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.

Authors:  Jung-Min Ahn; Frederik M Zimmermann; Satish Arora; Ole-Geir Solberg; Oskar Angerås; Katrine Rolid; Muzammil Rafique; Lars Aaberge; Kristjan Karason; Kozo Okada; Helen Luikart; Kiran K Khush; Yasuhiro Honda; Nico H J Pijls; Sang Eun Lee; Jae-Joong Kim; Seung-Jung Park; Lars Gullestad; William F Fearon
Journal:  Eur Heart J       Date:  2021-12-21       Impact factor: 35.855

4.  Myocardial Tissue Oxygenation and Microvascular Blood Volume Measurement Using a Contrast Blood Oxygenation Level-Dependent Imaging Model.

Authors:  Jeffrey M Dendy; Sean G Hughes; Jonathan H Soslow; Daniel E Clark; Cynthia B Paschal; John C Gore
Journal:  Invest Radiol       Date:  2022-04-13       Impact factor: 10.065

5.  Assessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation.

Authors:  Anthony W Castleberry; Adam D DeVore; Kevin W Southerland; James M Meza; William D Irish; Joseph G Rogers; Carmelo A Milano; Chetan B Patel
Journal:  ASAIO J       Date:  2016 May-Jun       Impact factor: 2.872

6.  Evolving concepts and treatment strategies for cardiac allograft vasculopathy.

Authors:  Rodolfo Denadai Benatti; David O Taylor
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

7.  Reduced Myocardial Flow Reserve by Positron Emission Tomography Predicts Cardiovascular Events After Cardiac Transplantation.

Authors:  Matthew C Konerman; John J Lazarus; Richard L Weinberg; Ravi V Shah; Michael Ghannam; Scott L Hummel; James R Corbett; Edward P Ficaro; Keith D Aaronson; Monica M Colvin; Todd M Koelling; Venkatesh L Murthy
Journal:  Circ Heart Fail       Date:  2018-06       Impact factor: 8.790

Review 8.  Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy.

Authors:  Nishant R Shah; Ron Blankstein; Todd Villines; Hafiz Imran; Alan R Morrison; Michael K Cheezum
Journal:  Curr Cardiovasc Imaging Rep       Date:  2018-09-24

9.  Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers.

Authors:  Martina Bona; Rahel K Wyss; Maria Arnold; Natalia Méndez-Carmona; Maria N Sanz; Dominik Günsch; Lucio Barile; Thierry P Carrel; Sarah L Longnus
Journal:  J Am Heart Assoc       Date:  2021-01-30       Impact factor: 5.501

10.  The relationship between endothelial progenitor cell populations and epicardial and microvascular coronary disease-a cellular, angiographic and physiologic study.

Authors:  Kim H Chan; Philippa J L Simpson; Andy S Yong; Louise L Dunn; Chirapan Chawantanpipat; Chijen Hsu; Young Yu; Anthony C Keech; David S Celermajer; Martin K C Ng
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.